clodronic acid has been researched along with Recrudescence in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adam, Z; Hájek, R; Jakubcová, R; Klincová, M; Krejcí, M; Mayer, J; Pour, L; Szturz, P; Zahradová, L | 1 |
| Melchior, R; Schumacher, R; Spranger, J; Zabel, B | 1 |
| Ashley, S; Kanis, J; McCloskey, E; Ottestad, L; Paterson, A; Powles, T; Scheffler, B; Schein, P; Smith, I; Tidy, A | 1 |
| Casciari, C; Cristallini, S; Filipponi, P; Gregorio, F; Policani, G | 1 |
| Bruce, NJ; Guest, JF; Kanis, JA; McCloskey, EV | 1 |
| Boyle, IT; Cowan, RA; Dryburgh, FJ; Fraser, WD; Gallacher, SJ; Patel, U; Ralston, SH | 1 |
| Atkins, RM; Beneton, MN; Gray, RE; Hamdy, NA; Kanis, JA; Percival, RC; Preston, CJ; Russell, RG; Urwin, GH; Yates, AJ | 1 |
| Adami, S; Bertoldo, F; Bolzicco, GP; Lo Cascio, V; Rizzo, A; Rossini, M; Salvagno, G; Suppi, R | 1 |
3 trial(s) available for clodronic acid and Recrudescence
| Article | Year |
|---|---|
Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026].
Topics: Bone Density Conservation Agents; Bone Diseases; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Clodronic Acid; Double-Blind Method; Female; Humans; Middle Aged; Neoplasm Staging; Placebos; Random Allocation; Recurrence; Survival Analysis | 2006 |
Paget's disease of bone: benefits of neridonate as a first treatment and in cases of relapse after clodronate.
Topics: Acute-Phase Reaction; Aged; Aged, 80 and over; Alkaline Phosphatase; Amino Acids; Bone Resorption; Clodronic Acid; Collagen; Collagen Type I; Diphosphonates; Drug Administration Schedule; Drug Resistance; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Osteitis Deformans; Pain; Peptides; Recurrence; Treatment Outcome | 1998 |
Comparison of three intravenous bisphosphonates in cancer-associated hypercalcaemia.
Topics: Administration, Oral; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Drug Administration Schedule; Drug Evaluation; Etidronic Acid; Humans; Infusions, Intravenous; Middle Aged; Neoplasms; Pamidronate; Randomized Controlled Trials as Topic; Recurrence; Time Factors | 1989 |
5 other study(ies) available for clodronic acid and Recrudescence
| Article | Year |
|---|---|
[Regression of an osteolytic lesion in a patient with multiple myeloma treated with clodronate after a successful therapy with bortezomib-based regimen].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Boronic Acids; Bortezomib; Clodronic Acid; Femur; Humans; Male; Multiple Myeloma; Osteolysis; Pyrazines; Radiography; Recurrence; Remission Induction | 2011 |
Effective parenteral clodronate treatment of a child with severe juvenile idiopathic osteoporosis.
Topics: Age Factors; Antimetabolites; Bone Density; Child; Clodronic Acid; Humans; Infusions, Parenteral; Male; Osteoporosis; Puberty; Recurrence | 2005 |
Economic impact of using clodronate in the management of patients with multiple myeloma.
Topics: Clodronic Acid; Cost-Benefit Analysis; Drug Costs; Fractures, Bone; Health Resources; Humans; Multiple Myeloma; Recurrence; Sensitivity and Specificity; Survival Analysis | 1999 |
Intravenous clodronate in the treatment and retreatment of Paget's disease of bone.
Topics: Administration, Oral; Alkaline Phosphatase; Biopsy; Bone and Bones; Clodronic Acid; Diphosphonates; Humans; Hydroxyproline; Infusions, Parenteral; Osteitis Deformans; Recurrence | 1985 |
The use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemia of malignancy.
Topics: Administration, Oral; Adult; Aged; Clodronic Acid; Diphosphonates; Female; Humans; Hypercalcemia; Infusions, Intravenous; Injections, Intramuscular; Male; Middle Aged; Neoplasms; Recurrence | 1987 |